Chronic Kidney Disease Requiring Hemodialysis Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Chronic Kidney Disease Requiring Hemodialysis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.

SarcopeniaChronic Kidney Disease Requiring HemodialysisRehabilitation Program
Brugmann University Hospital50 enrolled1 locationNCT07413315
Recruiting
Not Applicable

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

Chronic Kidney Disease Requiring Hemodialysis
University of Pittsburgh424 enrolled2 locationsNCT06978127
Recruiting
Not Applicable

Creation of Arteriovenous Fistulas for Hemodialysis Using the End-to-side Anastomotic Technique vs. Piggyback.

Chronic Kidney Disease Requiring Hemodialysis
Hospital Clinic of Barcelona130 enrolled1 locationNCT06997042
Recruiting
Not Applicable

DIALysis With EXpanded Solute Removal

Kidney DiseaseChronic Kidney Disease Requiring HemodialysisHemodialysis+5 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4,800 enrolled1 locationNCT06660277
Recruiting
Not Applicable

Aerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis Patients

Chronic Kidney Disease Requiring Hemodialysis
Cairo University60 enrolled2 locationsNCT07045064
Recruiting
Not Applicable

Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis

Chronic Kidney Disease Requiring Hemodialysis
Chittagong Medical College90 enrolled1 locationNCT06847139
Recruiting
Not Applicable

Effect of a Structured Physical Exercise Program on Arteriovenous Fistula Maturation for Hemodialysis in Chronic Kidney Disease Patients

Chronic Kidney Disease Requiring Hemodialysis
Unidade Local de Saúde de Coimbra, EPE128 enrolled1 locationNCT06960304
Recruiting
Phase 2

Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

Chronic Kidney Disease Requiring Hemodialysis
Maximo Agustin Schiavone80 enrolled1 locationNCT06929169